Skip to content

Fiber mHealth Intervention for Prediabetes

Preliminary Examination of an Innovative mHealth-Based Dietary Fiber Intervention to Improve Outcomes in Young Adults With Prediabetes: A Feasibility Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07491653
Acronym
GO-FAR
Enrollment
80
Registered
2026-03-24
Start date
2026-08-01
Completion date
2028-07-01
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prediabetes

Keywords

Diet, Young adults, Fiber, Diabetes

Brief summary

This is a single-arm feasibility trial to examine an mHealth intervention that combines high fiber education, home-delivered high fiber foods, and use of continuous glucose monitors.

Detailed description

This is a single-arm trial enrolling young adults (aged 18-39) with prediabetes (based on hemoglobin A1c). Enrolled individuals will complete baseline data collection in person to assess insulin resistance (venous blood samples). Enrolled individuals will then complete a three-month fully-mHealth based intervention focused exclusively on promoting greater fiber intake. Participants will receive weekly home-delivered shipments of high fiber foods and wear a continuous glucose monitor at two time points as a form of biofeedback. After the three months, participants will return for repeat assessment of insulin resistance. After that repeat assessment, participants will do a one-month observation period using cell phone-based ecological momentary assessments.

Interventions

BEHAVIORALGO-FAR

3-month intervention combining multiple behavior change techniques (biofeedback, adding objects to the environment, instruction on how to perform the behavior), all focused on helping people at more fiber.

Sponsors

University of Oklahoma
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Masking description

Masking not possible as single arm

Intervention model description

Single arm feasibility trial with pre/post assessments plus a 1-month observation period.

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Pre-diabetes based on HbA1c * Young adult, aged 18-39 years * Reside near Tulsa metro area * Ability to access/use a compatible smartphone * Proficient in English

Exclusion criteria

* Suspected eating disorder * Current glucagon-like peptide-1 receptor agonist use * Food allergies or intolerances * Currently pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Recruitment (as a measure of intervention feasibility)Evaluated at the end of the project period (2 years in total)Percentage of recruitment goal reached.
Retention of participants (as a measure of feasibility)Retention will be based on time retained in the study over a period of approximately 5 months (from enrollment to completion of follow-up data collection)Percentage of enrolled participants who remain in the study throughout the intervention period
Acceptability (as a measure of feasibility)Measured at the end of the 3-month interventionParticipants will rate their perceived acceptability of the intervention using a 5-point Likert scale question ("How would you rate this study intervention as a whole?" rated as Poor, Fair, Good, Very Good, Excellent.

Secondary

MeasureTime frameDescription
Dietary fiber intakeBaseline, after-intervention (3-months), and after a 4-week observation periodMeasured using the automated self-administered 24-hour recall
Glycemic control (hemoglobin A1c [HbA1c])Baseline and after the intervention (3 months)Measured via point-of-care testing devices
Insulin resistance (Homeostatic Model Assessment of Insulin Resistance [HOMA-IR])Baseline and after-intervention (3 months)Measured via venous blood samples

Countries

United States

Contacts

CONTACTAshlea Braun, PhD
Ashlea-Braun@ou.edu918.660.3080
PRINCIPAL_INVESTIGATORAshlea Braun, PhD

University of Oklahoma

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026